Related Experiment Video

Updated: May 29, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer?

Ruth Plummer1

  • 1Northern Institute for Cancer Research, Newcastle University, Paul O'Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. ruth.plummer@ncl.ac.uk

Breast Cancer Research : BCR
|September 3, 2011
PubMed

Insights

Poly(ADP-ribose) polymerase (PARP) inhibitors show promise for breast cancer treatment. These agents can be used alone or with chemotherapy, offering new therapeutic strategies for specific patient groups.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Poly(ADP-ribose) polymerase (PARP)-mediated DNA repair is crucial in cancer cells.
  • PARP inhibitors are emerging as a promising therapeutic strategy in oncology.
  • Specific subgroups of breast cancer may benefit from PARP inhibition.

Purpose of the Study:

  • To review the early clinical evidence for PARP inhibitors in breast cancer treatment.
  • To discuss the potential of PARP inhibitors as single agents and in combination therapy.
  • To highlight the distinct mechanisms of action and toxicity profiles of different PARP inhibitors.

Main Methods:

  • Review of early clinical studies, including Phase II trials, of PARP inhibitors in breast cancer.
  • Analysis of data on olaparib (oral PARP inhibitor) in BRCA-related tumors.
  • Evaluation of data on iniparib (intravenous PARP inhibitor) in combination with chemotherapy for triple-negative breast cancer.

Main Results:

  • Olaparib demonstrates activity as a single agent in BRCA-related breast tumors.
  • Iniparib combined with chemotherapy shows a survival advantage in triple-negative breast cancer compared to chemotherapy alone.
  • Iniparib does not significantly increase toxicity when used as a chemo-potentiating agent.

Conclusions:

  • PARP inhibitors represent a significant new class of anti-cancer agents.
  • These inhibitors have dual potential actions: as single agents inducing synthetic lethality and as chemo-potentiating agents.
  • Further clinical trials, including Phase III data, are anticipated to further define the role of PARP inhibitors in breast cancer therapy.

More Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...